Results 31 to 40 of about 1,533 (199)

Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors [PDF]

open access: yesInternational Journal of Molecular Sciences, 2020
The use of theragnostic radiopharmaceuticals in nuclear medicine has grown rapidly over the years to combine the diagnosis and therapy of tumors. In this review, we performed web-based and desktop literature research to investigate and explain the potential role of theragnostic imaging in pediatric oncology.
Andrea Cimini   +4 more
openaire   +3 more sources

Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect

open access: yesPharmaceutics, 2021
Due to the theragnostic potential of mesoporous silica nanoparticles (MSNs), these were extensively investigated as a novel approach to improve clinical outcomes.
Alex N. Frickenstein   +10 more
doaj   +1 more source

Preparation and Evaluation of 64Cu-Radiolabled Dual-Ligand Multifunctional Gold Nanoparticles for Tumor Theragnosis

open access: yesPharmaceuticals, 2023
Gold nanoparticles (AuNPs) are cutting-edge platforms for combined diagnostic and therapeutic approaches due to their exquisite physicochemical and optical properties. Using the AuNPs physically produced by femtosecond pulsed laser ablation of bulk Au in
Karim Mhanna   +11 more
doaj   +1 more source

Targeted Radiotherapeutics from 'Bench-to-Bedside'

open access: yesCHIMIA, 2020
he concept of targeted radionuclide therapy (TRT) is the accurate and efficient delivery of radiation to disseminated cancer lesions while minimizing damage to healthy tissue and organs.
Cristina Müller   +4 more
doaj   +1 more source

Micro/Nanobubbles Driven Multimodal Imaging and Theragnostics of Cancer [PDF]

open access: yesAdvanced Ultrasound in Diagnosis and Therapy, 2021
Ultrasound imaging has attracted great interest of researchers due to their application in cancer diagnosis and treatment. Ultrasound contrast agents, microbubbles and nanobubbles are widely explored as a multifunctional platform, not only carrying other
Xiaoting Zhang, BS, Zhifei Dai, PhD
doaj   +1 more source

Bacteriophages as Solid Tumor Theragnostic Agents [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
Cancer, especially the solid tumor sub-set, poses considerable challenges to modern medicine owing to the unique physiological characteristics and substantial variations in each tumor’s microenvironmental niche fingerprints. Though there are many treatment methods available to treat solid tumors, still a considerable loss of life happens, due to the ...
Srivani Veeranarayanan   +4 more
openaire   +2 more sources

Radiation Dosimetry of Theragnostic Pairs for Isotopes of Iodine in IAZA

open access: yesPharmaceutics, 2022
Theragnostic pairs of isotopes are used to infer radiation dosimetry for a therapeutic radiopharmaceutical from a diagnostic imaging study with the same tracer molecule labelled with an isotope better suited for the imaging task. We describe the transfer
Hans-S. Jans   +6 more
doaj   +1 more source

Unleashing novel horizons in advanced prostate cancer treatment: investigating the potential of prostate specific membrane antigen-targeted nanomedicine-based combination therapy

open access: yesFrontiers in Immunology, 2023
Prostate cancer (PCa) is a prevalent malignancy with increasing incidence in middle-aged and older men. Despite various treatment options, advanced metastatic PCa remains challenging with poor prognosis and limited effective therapies. Nanomedicine, with
Mingze He   +11 more
doaj   +1 more source

PET Oncological Radiopharmaceuticals: Current Status and Perspectives

open access: yesMolecules, 2022
Molecular imaging is the visual representation of biological processes that take place at the cellular or molecular level in living organisms. To date, molecular imaging plays an important role in the transition from conventional medical practice to ...
Mai Lin   +4 more
doaj   +1 more source

Molecular theranostics: principles, challenges and controversies. [PDF]

open access: yesJ Med Radiat Sci
Molecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Currie G.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy